PrisMN Phase 2 trial of budoprutug in Primary Membranous Nephropathy (pMN) initiated Phase 1 trial of budoprutug subcutaneous formulation initiated, with initial data expected in H1 2026 WELLESLEY ...
Send us a tip using our anonymous form. A daily briefing on what matters in the music industry Send us a tip using our anonymous form. Billboard is a part of Penske ...
Abstract: This paper presents a power-efficient ASIC for bio-impedance spectroscopy, as well as ECG and respiration recording. The ASIC includes a wideband stimulation current source with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback